FibroGen, Inc.
FGEN
$6.89
-$0.03-0.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.66% | -93.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.66% | -93.23% | |||
| Cost of Revenue | 819.71% | -96.20% | |||
| Gross Profit | -416.82% | -89.08% | |||
| SG&A Expenses | -2.86% | -52.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 87.12% | -78.97% | |||
| Operating Income | -137.31% | -451.01% | |||
| Income Before Tax | -93.51% | 49.26% | |||
| Income Tax Expenses | 0.00% | -83.33% | |||
| Earnings from Continuing Operations | -93.49% | 49.28% | |||
| Earnings from Discontinued Operations | -19.67% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -74.20% | 205.26% | |||
| EBIT | -137.31% | -451.01% | |||
| EBITDA | -145.95% | -333.88% | |||
| EPS Basic | -74.20% | 204.93% | |||
| Normalized Basic EPS | -114.14% | -622.14% | |||
| EPS Diluted | -74.20% | 204.93% | |||
| Normalized Diluted EPS | -114.14% | -622.14% | |||
| Average Basic Shares Outstanding | 0.12% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||